Suhexiang pills inhibit ischemia stroke via targeting miR-24–3p to promote the activation of Keap1/Nrf2 signaling pathway
2025 · Brain Research Bulletin · 0 citations
https://doi.org/10.1016/j.brainresbull.2025.111478
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
4
Citations
1
h-index
0
i10-index
Mingcheng He is an academic researcher from Hubei University of Medicine. The author has contributed to research in topics: High-pressure geophysics and materials & Hydrogen Storage and Materials & Hybrid Renewable Energy Systems. The author has an h-index of 1, co-authored 4 publications.
ORCID: 0009-0001-2747-9264Click to start Chat